Arcutis Biotherapeutics (ARQT.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov26

Mizuho Securities Reiterates Buy Rating on Arcutis Biotherapeutics

21:57

Nov25

Arcutis Biotherapeutics Inc Director Lin Sue-Jean Sells and Exercises Options

23:31

Nov24

Akutsis Biotech CEO Disposes of Company Common Stock

23:46

Nov21

Halley E. Gilbert Disposed of Arcutis Biotherapeutics Inc. Common Stock

23:22

Nov18

Krishnamohan Neha Sells Shares of Arcutis Biotherapeutics Inc

01:01

Nov17

FDA Accepts Arcutis Biotherapeutics Inc.'s Supplemental NDA for ZORYVE® Cream

13:00

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 99.22 M, Net Income 7.41 M, EPS 0.058

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 81.5 M, Net Income -15.89 M, EPS -0.125

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 65.85 M, Net Income -25.06 M, EPS -0.1988

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More